Idogen appointed Christina Herder as new acting CEO by the board of directors. Herder has for the past five years been a board member of Idogen and also has more than 30 years of experience in several senior positions in the pharmaceutical industry.
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.79% | 21.93B | |
-6.03% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |